Report cover image

Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published May 20, 2024
Length 152 Pages
SKU # GBDT18902352

Description

Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Cardiac Valve Repair Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac valve repair devices are used in the Open-Heart surgery to repair the malfunctioning of valves.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Valve Repair Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Valve Repair Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Valve Repair Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

152 Pages
  • About GlobalData
    • Cardiac Valve Repair Devices Overview
    • Cardiac Valve Repair Devices - Pipeline Products by Stage of Development
    • Cardiac Valve Repair Devices - Pipeline Products by Segment
    • Cardiac Valve Repair Devices - Pipeline Products by Territory
    • Cardiac Valve Repair Devices - Pipeline Products by Regulatory Path
    • Cardiac Valve Repair Devices - Pipeline Products by Estimated Approval Date
    • Cardiac Valve Repair Devices - Ongoing Clinical Trials
    • Cardiac Valve Repair Devices Companies - Pipeline Products by Stage of Development
    • Cardiac Valve Repair Devices - Companies Pipeline Products by Stage of Development
    • 4Tech Cardio Ireland Ltd Company Overview
    • Affluent Medical SASU Company Overview
    • Ample Medical Inc Company Overview
    • Anchorvalve Company Overview
    • Ancora Heart Inc Company Overview
    • Approxima Srl Company Overview
    • Asan Medical Center Company Overview
    • BioVentrix Inc Company Overview
    • Boston Children's Hospital Company Overview
    • Boston Scientific Corp Company Overview
    • Cardiac Implants LLC Company Overview
    • Cardiosolutions Inc Company Overview
    • Cedars-Sinai Medical Center Company Overview
    • Celyad Oncology SA Company Overview
    • Collplant Biotechnologies Ltd Company Overview
    • Columbia University Company Overview
    • ConKay Medical Systems Inc Company Overview
    • CoreMedic AG Company Overview
    • CUBE SRL Company Overview
    • Edwards Lifesciences Corp Company Overview
    • Emory University Company Overview
    • Georgia Institute of Technology Company Overview
    • Hangzhou DeJin Medtech Co Ltd Company Overview
    • Hanxin Medical Technology (Shenzhen) Co Ltd Company Overview
    • Harpoon Medical Inc Company Overview
    • HVR Cardio Oy Company Overview
    • Kardium Inc Company Overview
    • Kekai Life Sciences Company Overview
    • Lepu Medical Technology (Beijing) Co Ltd Company Overview
    • LuSeed Vascular Company Overview
    • Mardil Medical, Inc. Company Overview
    • Mayo Clinic Company Overview
    • Meacor Inc Company Overview
    • Medical University of Vienna Company Overview
    • Meril Life Sciences Pvt Ltd Company Overview
    • MiCardia Corp Company Overview
    • Michigan Critical Care Consultants Inc Company Overview
    • Micro Interventional Devices, Inc. Company Overview
    • MicroPort CardioFlow Medtech Corp Company Overview
    • Millipede LLC Company Overview
    • Mitral Print Inc Company Overview
    • Mitralflex Sarl Company Overview
    • Mitralign Inc Company Overview
    • Mitre Medical Corp Company Overview
    • MVRx, Inc. Company Overview
    • Occlufit AG Company Overview
    • P+F Products + Features GmbH Company Overview
    • Pi-Cardia Ltd Company Overview
    • Rambam Health Care Campus Company Overview
    • SCR, Inc. Company Overview
    • Shanghai Shenqi Medical Technology Co Ltd Company Overview
    • Strait Access Technologies (Pty) Ltd Company Overview
    • Syntach AB Company Overview
    • Tau Pnu Medical Co., Ltd. Company Overview
    • Tel Aviv Sourasky Medical Center Company Overview
    • Tgen Tech LLC Company Overview
    • TransCardiac Therapeutics, LLC (Inactive) Company Overview
    • Transmural systems LLC Company Overview
    • TTK Healthcare Ltd Company Overview
    • University of Manitoba Company Overview
    • University of South Carolina Company Overview
    • Valcare Medical Company Overview
    • valsculp Company Overview
    • Valtech Cardio Ltd Company Overview
    • Vesalius Cardiovascular Inc Company Overview
    • Viacor Inc Company Overview
    • Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results
    • Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
    • Apr 22, 2024: Genesee BioMedical Receives FDA 510(k) Clearance for TransForm McCarthy Mitral Annuloplasty Ring (TF)
    • Apr 17, 2024: Annoviant wins $2.9m NIH grant for paediatric heart conduits
    • Apr 15, 2024: Edwards Lifesciences Appoints New China Head
    • Apr 08, 2024: Cardiology Team Performs Novel Heart Valve Repair with Newly Approved Device
    • Mar 29, 2024: MicroPort CardioFlow Medtech Full Year 2023 Earnings
    • Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
    • Feb 22, 2024: NeoChord Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
    • Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
    • Feb 14, 2024: AMC Professor Joon Bum Kim invited to lecture at Stanford Medicine, USA
    • Jan 15, 2024: Affluent Medical : Pre-submission Dossier for the 510(K) of Medical Device Kaliostm Filed With FDA for Review
    • Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
    • Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
    • Sep 13, 2023: Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities
    • Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman
    • Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman
    • Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
    • Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
    • Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
    • Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
    • Aug 09, 2023: Collplant Biotechnologies Announces Date for 2023 Second Quarter Financial Results and Conference Call Information
    • Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
    • Jun 15, 2023: Genesee BioMedical Receives 510(k) Clearance for WellsForm Tricuspid Annuloplasty Band (WF)
    • May 24, 2023: CollPlant Biotechnologies announces first quarter financial results for 2023 and provides corporate update
    • May 23, 2023: Study: Transcatheter Mitral Valve Repair Safe, Successful
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.